Approval · Notice of Compliance 2042 · 1999
ADVAIR DISKUS: Notice of Compliance 2042
Issued September 3, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2042
- Date
- September 3, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bronchodilator and corticosteroid for inhalation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVAIR DISKUS | 02240835 | Marketed |
| ADVAIR DISKUS | 02240836 | Marketed |
| ADVAIR DISKUS | 02240837 | Marketed |
Medicinal ingredients
- FLUTICASONE PROPIONATE 100 MCG per PCK
- SALMETEROL XINAFOATE 50 MCG per PCK
- FLUTICASONE PROPIONATE 250 MCG per PCK
- FLUTICASONE PROPIONATE 500 MCG per PCK